BW-20805

DRUG2 trials

Sponsors

Shanghai Argo Biopharmaceutical Co., Ltd.

Conditions

HVHereditary Angioedema (HAE)

Phase 1

A Phase 1 Clinical Study of BW-20805-2-1001 in Healthy Participants

Not yet recruitingNCT07528053

Shanghai Argo Biopharmaceutical Co., Ltd.HV

Start: 2026-04-28End: 2027-11-05Target: 24Updated: 2026-04-21

Phase 2

A Phase 2 in Adult Subjects With Hereditary Angioedema

Active, not recruitingNCT06846398

Shanghai Argo Biopharmaceutical Co., Ltd.Hereditary Angioedema (HAE)

Start: 2025-02-28End: 2028-03-30Updated: 2026-04-17